The Effects of Ranolazine on CPET Parameters in Ischemic Cardiomyopathy Patients (ERIC)

NCT01705509 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Study terminated due to lack of resources.

Conditions

Cardiomyopathy

Interventions

DRUG: Ranolazine

Sponsor

Cardiovascular Institute of the South Clinical Research Corporation

Collaborators

[object Object]